# Filing Detail

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001641172-25-002426
Filing Date
2025-04-02
Accepted
2025-04-02 17:19:57
Documents
99
Period of Report
2024-12-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 |  | form10-k.htm iXBRL | 10-K | 1908870
2 |  | ex4-3.htm | EX-4.3 | 136386
3 |  | ex19-1.htm | EX-19.1 | 167473
4 |  | ex21-1.htm | EX-21.1 | 3151
5 |  | ex23-1.htm | EX-23.1 | 3141
6 |  | ex31-1.htm | EX-31.1 | 12549
7 |  | ex31-2.htm | EX-31.2 | 11607
8 |  | ex32-1.htm | EX-32.1 | 5738
9 |  | ex32-2.htm | EX-32.2 | 5815
10 |  | logo_001.jpg | GRAPHIC | 7178
11 |  | form10-k_002.jpg | GRAPHIC | 65609
12 |  | form10-k_003.jpg | GRAPHIC | 20184
13 |  | form10-k_004.jpg | GRAPHIC | 37504
14 |  | form10-k_005.jpg | GRAPHIC | 44194
15 |  | form10-k_006.jpg | GRAPHIC | 83359
16 |  | form10-k_007.jpg | GRAPHIC | 30464
17 |  | form10-k_008.jpg | GRAPHIC | 11245
18 |  | form10-k_009.jpg | GRAPHIC | 56383
19 |  | form10-k_010.jpg | GRAPHIC | 24591
| Complete submission text file | 0001641172-25-002426.txt |  | 8906494

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
20 | XBRL SCHEMA FILE | tvgn-20241231.xsd | EX-101.SCH | 52150
21 | XBRL CALCULATION FILE | tvgn-20241231_cal.xml | EX-101.CAL | 75051
22 | XBRL DEFINITION FILE | tvgn-20241231_def.xml | EX-101.DEF | 291831
23 | XBRL LABEL FILE | tvgn-20241231_lab.xml | EX-101.LAB | 479434
24 | XBRL PRESENTATION FILE | tvgn-20241231_pre.xml | EX-101.PRE | 409840
101 | EXTRACTED XBRL INSTANCE DOCUMENT | form10-k_htm.xml | XML | 868668

Mailing Address 15 INDEPENDENCE BOULEVARD, SUITE 410 WARREN NJ 07059
Business Address 15 INDEPENDENCE BOULEVARD, SUITE 410 WARREN NJ 07059 646-807-8832
Tevogen Bio Holdings Inc. (Filer) CIK: 0001860871 (see all company filings)

EIN.: 981597194 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-41002 | Film No.: 25806133
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)